SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense market interest and significant price volatility as it gains traction as a decentralized, community-driven project centered on the intersection of live music, Web3 entertainment, and social impact initiatives. The community is actively debating the token's explosive price action, while supporters point to upcoming festival appearances and speculative partnership rumors as catalysts for continued momentum.

Maulcoin

Maulcoin is capturing attention as a community-driven project with an active, enthusiastic base that is prioritizing long-term growth and organic building over typical short-term pump-and-dump tactics. Supporters are heavily focused on breaking key market capitalization milestones to trigger planned airdrops and are actively working to gain broader traction despite the current lack of a formal exchange chart.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

CockCardano is trending as the community rallies around its unique integration of memecoin culture with real-world business revenue, specifically via its chicken wing food truck operations. Investors are actively discussing the project's buyback mechanisms and staking arena, maintaining a high level of engagement while tracking its performance within the Cardano ecosystem.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is currently experiencing high volume and increased community interest, with traders actively debating its potential for a massive breakout as it is frequently compared to other volatile, low-market-cap assets. While some enthusiasts point to speculative partnership rumors and technical chart patterns, others remain cautious of potential market manipulation and the risk of a quick pullback.

Snek is a cultural movement and leading currency for meme creators worldwide.

SNEK

SNEK is trending as it cements its position as a leading meme coin on the Cardano blockchain, fueled by strategic exchange listings, a major treasury withdrawal for growth, and high-visibility partnerships like selling energy drinks through the Cocky Wings food truck franchise. The community remains bullish, actively discussing its long-term potential to hit a billion-dollar market cap while highlighting the utility of its expanding ecosystem and ongoing real-world revenue initiatives.

Frontline Plc is an international shipping company, which engages in the ownership and operation of oil and product tankers. It also offers the seaborne transportation of crude oil and oil products. The company was founded in 1985 and is headquartered in Limmasol, Cyprus.

Frontline Plc

Frontline Ltd

Frontline Ltd. (FRO) is currently trending as investors debate the impact of shifting geopolitical tensions and vessel rerouting around the Cape of Good Hope, which significantly extends voyage times and tightens global tanker supply. The community is actively discussing how these disruptions, combined with the company's variable dividend policy and the potential for elevated freight rates, position the stock as a key beneficiary of the ongoing oil market volatility.

Eversource Energy engages in the generation, transmission, and distribution of natural gas and electricity. It operates through the following segments: Electric Distribution, Electric Transmission, Natural Gas Distribution, Water Distribution, and Other. The Electric Distribution segment distributes electricity to retail customers. The Electric Transmission segment owns and maintains transmission facilities through CL&P, NSTAR Electric, PSNH, and WMECO. The Natural Gas Distribution segment transmits and distributes natural gas to retail customers. The Water Distribution segment operates five separate regulated water utilities in Connecticut, Massachusetts, and New Hampshire. The company was founded on July 1, 1966, and is headquartered in Springfield, MA.

Eversource Energy

Eversource Energy (ES) is currently a focal point for investors as they navigate a challenging regulatory environment and recent asset impairment charges, with the community actively debating the company's long-term utility stability versus its ongoing offshore wind project transitions. Analysts remain split, with some highlighting the stock's defensive dividend potential at current price levels while others express concerns over regional rate-setting pressures.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is trending as investors weigh its pivot toward wealth and asset management, which now accounts for over half of its revenue, against the firm's recent headlines regarding private credit fund redemption caps and potential IPO involvement. The community is actively debating the stock's stability amid macro volatility and its role in high-profile upcoming public offerings.

iShares Trust - iShares MSCI China ETF

iShares MSCI China ETF

The iShares MSCI China ETF is trending as investors debate the impact of potential U.S. trade tariffs on Chinese imports alongside speculation regarding the country's economic stimulus efforts. Community discussions are heavily focused on navigating geopolitical risks, evaluating China's market valuations, and interpreting diverging analyst perspectives on whether recent policy shifts signal a sustainable recovery or continued volatility.

iShares Trust - iShares China Large-Cap ETF

iShares China Large-Cap ETF

The iShares China Large-Cap ETF (FXI) is currently experiencing heightened volatility and intense investor debate as markets react to the growing risk of renewed U.S.-China trade friction, sparked by warnings of potential high-level tariffs. While some community members are attempting to navigate short-term technical setups, the broader discussion is dominated by conflicting outlooks on whether current geopolitical tensions will trigger a lasting downturn or if fundamental valuation gaps will eventually drive a rotation back into Chinese equities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update

VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update PR Newswire...

VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium

VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in...

Volition Announces Mayo Clinic Study Demonstrates Nu.Q Concentrations are Elevated in Trauma Patients

Volition Announces Mayo Clinic Study Demonstrates Nu.Q Concentrations are Elevated in Trauma Patients Volition Announces Mayo Clinic Study Demonstrates Nu.Q Concentrations are Elevated in Trauma...

VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update

VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update PR...

VolitionRx Reports Over 95% Early Cancer Detection in Breakthrough Liquid Biopsy Study

VolitionRx Limited (NYSE:VNRX) unveiled promising new data that could reshape the landscape of early cancer detection, reporting over 95% sensitivity in identifying stage I and II cancers using its proprietary Capture-Seq liquid biopsy technology.

<ul class="summary-bullets"><li>Volition stated in its announcement that the detection rate for stage I cancer was 94%, with its Capture-Seq method detecting in 17 of 18 samples.</li><li>Its detection rate for stage II cancer stood at 96%, stage III cancer at 100%, and stage IV cancer at 91%.</li><li>Volition stated that its Capture-Seq method overcomes the hurdles in the liquid biopsy space, where the vast majority of circulating DNA in blood plasma samples comes from healthy cells rather than cancer cells.</li></ul>VolitionRx (VNRX) shares ripped more than 34% in Wednesday’s pre-market trade&nbsp;before paring gains to hover 16% higher in the opening trade after the company announced proof-of-concept data from a blinded validation cohort for the detection of cancer.The company said that it has developed a new liquid biopsy method, and during a blind validation cohort, it achieved over 95% sensitivity for stage I &amp; II cancers with 95% specificity.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/VNRX">Volition</a> trended in the ‘bullish’ territory, with message volumes at ‘extremely high’ levels at the time of writing.<h2 class="st-heading-2">Detection Rates Across Cancer Stages</h2>Volition stated in its announcement that the detection rate for stage I cancer was 94%, with its Capture-Seq method detecting in 17 of 18 samples. Its detection rate for stage II cancer stood at 96%, stage III cancer at 100%, and stage IV cancer at 91%."We are now releasing the data from a blinded validation cohort of 81 subjects and are extremely encouraged by the results, particularly in early-stage cancer detection,” said Volition’s Chief Scientific Officer, Jake Micallef.The company’s Chief Commercial Officer, Gael Forterre, said that this technology represents a Total Addressable Market of nearly $23 billion for human Multi-Cancer Early Detection (MCED) tests, and $13 billion for Minimal Residual Disease (MRD) tests on an annualized basis.“We are in active discussions with several large liquid biopsy and diagnostic companies to accelerate the development and launch of this technology as soon as possible,” Forterre added.<h2 class="st-heading-2">What Is Capture-Seq?</h2>Volition stated that its Capture-Seq method overcomes the hurdles in the liquid biopsy space, where the vast majority of circulating DNA in blood plasma samples comes from healthy cells rather than cancer cells. This makes it hard to detect the disease.The company says its method solves this problem, producing more than 99% pure cancer-derived plasma DNA sequence sets for liquid biopsy. This filters out the noise and improves detection accuracy.<a href="https://stocktwits.com/symbol/VNRX">VNRX stock</a> is down 23% year-to-date and 63% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 15% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/avxl-stock-tanks-anavex-withdraws-alzheimers-drug-blarcamesine-eu/cZ3YF8WRISf">AVXL Stock Tanks After Anavex Withdraws EU Bid For Alzheimer's Drug</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

VNRX Stock Soars 34% Pre-Market — What's Driving The Rally?

The company said it has developed a new liquid biopsy method, and in a blinded validation cohort, it achieved over 95% sensitivity for stage I & II cancers with 95% specificity.

Equity

Volition Announces Detection of Over 95% of Early-Stage Cancers

Volition Announces Detection of Over 95% of Early-Stage Cancers Volition Announces Detection of Over 95% of Early-Stage Cancers PR Newswire HENDERSON, Nev., March 25, 2026 Blinded validation cohort...

<ul class="summary-bullets"><li>The company submitted an updated manuscript detailing a new two-step method to remove nearly all non-cancer DNA.</li><li>Early results showed no false positives and all cancers detected in the first group, along with strong validation in a second blinded cohort.</li><li>VolitionRx published a research paper in December 2025, that highlighted its Capture-Seq method for cancer detection.</li></ul>Shares of VolitionRx (VNRX) gave up a part of its pre-market gains to trade 30% higher on Wednesday after the diagnostics company unveiled what it called a potential breakthrough in cancer detection. The company said it was successful in isolating more than 99% pure circulating tumor-derived DNA (ctDNA) from blood samples of cancer patients.<a href="https://stocktwits.com/symbol/VNRX">VNRX stock</a> breached its 100-day moving average (100-DMA) for the first time since Oct. 8, 2025.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.tradingview.com/chart/teA7VKVN/?symbol=AMEX%3AVNRX"><img src="https://news.stocktwits-cdn.com/VNRX_jpg_e886d96646.webp" alt="VNRX.jpg"></a>Source: TradingViewThe company submitted an updated manuscript detailing a new two-step method that combines physical sample enrichment with advanced bioinformatics to remove nearly all non-cancer DNA. This addresses a key challenge in liquid biopsy, where most circulating DNA typically comes from healthy cells.“Our continuing work on CTCF-bound DNA has revealed what we believe to be an unprecedented new discovery; that there is almost no CTCF-bound DNA in healthy plasma and almost all CTCF-bound DNA in the blood of a cancer patient is derived from cancer cells – i.e. it is virtually pure circulating tumor-derived DNA,” said Jake Micallef, Chief Scientific Officer of Volition.“Removal of background normal cell free DNA from the blood to reveal this level of tumor derived DNA has been a long term goal of liquid biopsy. I believe this is a world-first and could, in my opinion, represent the biggest scientific breakthrough in cancer testing and monitoring in recent years,” Micallef added.The early results are encouraging, with no false positives and all cancers detected in the first group, along with strong validation in a second blinded cohort, VolitionRx said. The company is now working on further testing in early-stage cancers.<h2 class="st-heading-2">VolitionRx’s Capture-Seq Method for Cancer Detection</h2>VolitionRx published a research paper in December 2025, that highlighted its Capture-Seq method and novel biomarkers for cancer detection. The technology enables accurate and potentially low-cost testing across multiple cancers.&nbsp;It works by enriching ultrashort DNA fragments in blood, achieving a 180-fold increase in detection sensitivity. This approach focuses on DNA within chromosome fragments, unlike traditional methods that analyze extracted DNA.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits completely flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, accompanied by ‘extremely high’ message volumes.Despite shedding gains, retail chatter remained primarily bullish, with one user asking for patience.<stembedurl>https://stocktwits.com/SuellenD/message/647851536</stembedurl>Another user said buy the dip.<stembedurl>https://stocktwits.com/SuellenD/message/647840635</stembedurl>Year-to-date, the stock has shed around 8%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Artistic representation of a trending chart.

Why Is VNRX Stock Soaring Over 30% Today?

The company said it can isolate pure tumor DNA from blood, which potentially solves a key bottleneck in liquid biopsy.

Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA

Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating...

Volition Announces First Ever Automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems

Volition Announces First Ever Automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems Volition Announces First Ever Automated Nu.Q Vet Cancer Test with Fujifilm Vet Systems PR Newswire HENDERSON...

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.04	--	--	N/A
Q4 '25	-$0.04	--	--	N/A
Q3 '25	-$0.04	-$0.05	-13.64%	MISSED
Q2 '25	-$0.06	-$0.06	-7.14%	MISSED
Q1 '25	-$0.04	-$0.06	-38.89%	MISSED

VNRX
VolitionRX Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest VNRX News

VNRXVolitionRX Ltd